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Why has so much variation arisen in 
mechanisms of transcriptional repres-
sion? Perhaps customized transcrip-
tion silencing mechanisms coevolved 
with specific developmental strate-
gies and needs. For example, it may 
be important that repression by PIE-1 
is rapidly reversible because germ cell 
precursors in the early embryo divide 
to generate somatic daughter cells that 
must become transcriptionally active 
quickly. Sequestration or replace-
ment of general transcription factors 
may simply be an effective method for 
blocking or redirecting transcription, as 
has been observed in some organisms 
where specialized TAFs redirect tran-
scription programs toward germline 
genes (Wright et al., 2006). There are 
many ways to alter transcription glob-
ally in order to influence differentiation. 
Although OMA proteins and PIE-1 are 
not widely conserved across species, 
it seems likely, as Guven-Ozkan et al. 
point out, that similar mechanisms may 
be used in higher organisms to broadly 
regulate transcription and to forestall 
differentiation.
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Obesity is characterized by chronic activation of inflammatory pathways in peripheral tissues. In 
this issue, Zhang et al. (2008) demonstrate that inflammation also occurs in the central nervous 
system where it disrupts activity of the hypothalamus leading to resistance to leptin that is medi-
ated by activation of IKK and the endoplasmic reticulum stress response.The development of obesity and type 
2 diabetes is influenced by a complex 
interaction of environmental and genetic 
factors. It is becoming clear that obesity 
is characterized by chronic activation 
of inflammatory pathways and that this 
chronic inflammation is causally linked 
to insulin resistance and type 2 diabetes 
(Hotamisligil, 2006). Although this inflam-
matory etiology is principally studied 
in peripheral organs, such as liver and 
adipose tissue, obesity-induced inflam-
matory changes and their impact on 
leptin and insulin action have also been 
reported in the central nervous system 
(CNS), including the hypothalamus (De 
Souza et al., 2005). Insulin action in the 
CNS has systemic consequences, and 
normal functioning of the hypothalamus 
is paramount not just for regulation of 
food intake but also for broader metabolic 
homeostasis. Conversely, central signals 20 Cell 135, October 3, 2008 ©2008 Elseviercan control peripheral glucose metabo-
lism and insulin sensitivity, particularly in 
the liver. In the brain, the hypothalamus 
is a primary site of convergence and 
integration of multiple nutrient-related 
signals including central and peripheral 
neural signals as well as hormonal and 
nutritional cues. The arcuate nucleus, 
situated in the mediobasal hypothalamus 
(MBH), integrates hormonal signals (such 
as insulin, leptin, and ghrelin) and meta-
bolic fuels (such as glucose and lipids) to 
regulate food intake and energy balance 
(Cone, 2005) (Figure 1). Impaired regula-
tion of arcuate nucleus neurons leads not 
only to obesity but also to aberrant glu-
cose homeostasis, although the mecha-
nisms underlying this neuronal dysfunc-
tion are not yet clearly resolved.
Activation of inflammatory signaling 
pathways by immune signals or nutri-
ents inhibits insulin action. This inhibitory  Inc.input involves activation of inflammatory 
kinases such as c-Jun N-terminal kinase 
(JNK) and inhibitor of kappa B kinase 
(IKKβ). Activation of both pathways in the 
liver leads to systemic insulin resistance, 
whereas inhibition of JNK or IKK pathways 
protects animals against obesity-induced 
insulin resistance and obesity-induced 
expression of inflammatory cytokines 
(Hotamisligil, 2006). Although inflam-
matory changes have been detected in 
the CNS of obese mice (De Souza et al., 
2005), the biological consequences and 
underlying mechanisms remain unclear. 
In this issue of Cell, Zhang et al. (2008) 
now offer important insights into the link 
between nutritional signals and activation 
of inflammatory and stress pathways in 
the hypothalamus.
In their study, Zhang and colleagues 
found that IKKβ is expressed principally 
in neurons of the MBH but is normally 
figure 1. IKKβ/nf-κB Activation and eR stress in the Hypothalamus Result in Leptin and Insulin Resistance in the cns
Increased exposure to macronutrients activates sensing pathways in the hypothalamus, which in turn suppress food intake and regulate hepatic glucose out-
put. Both acute and chronic overnutrition result in the activation of IKKβ in the hypothalamus, leading to impaired insulin and leptin signaling, which, at least in 
part, involves the protein SOCS3. Obesity and elevated IKKβ also trigger ER stress in the hypothalamus (red arrows, text), which leads to leptin resistance in the 
CNS. The contribution of other potential UPR branches and other inflammatory signaling molecules such as JNK remains to be examined. ER stress could also 
impair CNS function by interfering with the release of neurotransmitters. Given that both nutrients and inflammatory signaling could engage the mTOR pathway, 
this molecule is also shown as a potential player in obesity-induced ER stress in the CNS.inactive. However, chronic (dietary or 
genetic obesity) or acute (glucose or 
oleic acid exposure) overnutrition results 
in IKKβ/NF-κB activation. Interestingly, 
nutrient-induced activation of IKKβ/
NF-κB in the hypothalamus is not asso-
ciated with an overt increase in cytokine 
production in MBH neurons. Experimen-
tal activation of the IKKβ/NF-κB signaling 
pathway in the hypothalamus, through 
virus-mediated introduction of a con-
stitutively active IKKβCA, leads to weight 
gain and increased food intake in mice 
fed a high-fat diet, along with remarkably 
impaired insulin and leptin signaling in 
the hypothalamus. Moreover, the authors 
demonstrate that suppression of IKKβ/
NF-κB signaling in the MBH protects 
against insulin and leptin resistance, and 
obesity. Negative regulation of insulin 
and leptin receptor signaling may involve 
IKKβ-mediated elevation of the protein 
SOCS3, which is known to block both 
insulin and leptin action (Hotamisligil, 
2006; Howard and Flier, 2006).
How does the brain interpret the pres-
ence of metabolic overload and trans-
mit signals that trigger an inflammation 
response? In peripheral tissues, the 
endoplasmic reticulum (ER), when under 
stress, interferes with insulin action and promotes weight gain and type 2 dia-
betes (Hotamisligil, 2006). ER stress 
initiates a complex adaptive signaling 
network also known as the unfolded pro-
tein response (UPR) (Figure 1). Mount-
ing evidence suggests that there is a 
link between the UPR and inflamma-
tion mediated by JNK and IKK/NF-κB 
(Hotamisligil, 2006). During the UPR, 
PERK-mediated attenuation of transla-
tion results in a shift in the ratio of IκB 
to NF-κB, thereby leading to activation 
of NF-κB. Also during ER stress, another 
UPR regulator, IRE1, binds to the adaptor 
protein TRAF2 (tumor-necrosis factor-α 
receptor-associated factor 2), which in 
turn mediates activation of both JNK 
and IKK (Figure 1). Zhang et al. (2008) 
now provide evidence that insulin and 
leptin resistance in the hypothalamus 
due to increased IKKβ activity might be 
caused by ER stress in the brain. Indeed, 
markedly elevated p-PERK and p-eIF2α 
expression was evident in the hypothala-
mus of mice with diet-induced obesity. 
Interestingly, activation of IKKβ also 
led to ER stress in the hypothalamus, 
whereas blocking IKKβ activity in obese 
animals suppressed obesity-induced ER 
stress. In the ob/ob obese mouse, ER 
stress in peripheral tissues can be alle-Cell 1viated using chemical chaperones such 
as PBA and TUDCA. Zhang and col-
leagues now demonstrate that obesity-
induced ER stress in the hypothalamus 
due to diet could also be suppressed by 
administration of TUDCA, which resulted 
in reduced food intake and decreased 
body weight. Together with the effects 
observed in hypothalamic leptin sig-
naling, these results demonstrate that 
hypothalamic ER stress and IKK activa-
tion are mediators of leptin resistance in 
vivo.
Notably, the authors found that ER 
stress is both an upstream mediator 
and a downstream consequence of the 
activation of IKKβ/NF-κB because IKKβ 
activation alone could elicit ER stress 
responses in the hypothalamus. So why 
does inflammatory signaling induce ER 
stress but not activation of widespread 
cytokine production in the hypothala-
mus during overnutrition? Growing evi-
dence suggests that activation of IKK 
does not solely reflect the transcriptional 
effects of NF-κB but may involve NF-κB-
independent effects such as inhibition 
of IRS-1 in adipocytes and liver cells 
(Hotamisligil, 2006). IKK has also been 
detected in the mTOR-Raptor complex, 
and its activation is linked to mTOR acti-35, October 3, 2008 ©2008 Elsevier Inc. 21
vation through direct phosphorylation 
of the protein TSC1 (tuberous sclerosis 
complex 1) (Lee et al., 2007). Interestingly, 
mTOR forms an important molecular 
link between insulin and leptin signaling 
(Cota et al., 2006). In addition, constitu-
tive activation of mTOR triggers ER stress 
and inhibition of insulin action through 
JNK-mediated serine phosphorylation 
of IRS1 (Ozcan et al., 2008). Hence, it 
is intriguing to speculate that IKK-medi-
ated activation of mTOR could be one 
of the potential mechanisms underlying 
IKK-induced ER stress in the hypothala-
mus during overnutrition. It remains to 
be seen whether such a mechanism also 
involves JNK and whether activation of 
these pathways collectively produces ER 
stress in the hypothalamus with distinct 
inflammatory properties.
There are two populations of neurons 
that reside in the arcuate nucleus of the 
hypothalamus: the pro-opiomelanocortin 
“POMC” cells, which produce “anorexi-
genic” (appetite-suppressing) neuropep-
tides, and the agouti-related protein and 
neuropeptide Y-producing “NPY/AGRP” 
cells, which produce the “orexigenic” 
(appetite-stimulating) neuropeptides. 
Both of these neuronal populations 
express a functional leptin receptor. Lep-
tin activates the POMC neurons directly 
but blocks the activity of neurons pro-
ducing NPY/AGRP. In addition, NPY/
AGRP neurons produce the inhibitory 
neurotransmitter that suppresses POMC 
neuronal activity. It has been suggested 22 Cell 135, October 3, 2008 ©2008 Elsevierthat the juxtapositioning of the arcuate 
nucleus next to the median eminence 
and the direct contact of secretory neu-
rons in the arcuate nucleus with the cir-
culation might render this region more 
sensitive to systemic mediators (glucose, 
lipids, and cytokines). Another possibil-
ity is that nutrient-induced hypothalamic 
ER stress is a regulatory event affecting 
neuropeptide release that alters POMC-
NPY/AGRP circuits hence modulating 
food intake and energy balance.
The Zhang et al. study provides an 
intriguing link between metabolic inflam-
mation and dysfunction of the hypo-
thalamus through activation of IKKβ. 
Moreover, insulin and leptin resistance 
of the hypothalamus induced by IKK/
NF-κB are both mediated by ER stress. 
Future studies will need to investigate 
how hypothalamic ER stress directly 
results in impaired insulin and/or lep-
tin signaling and which branches of the 
UPR are activated in an inflamed hypo-
thalamus. Is IKKβ- or ER stress-induced 
leptin resistance limited to the CNS or 
does it also occur in peripheral tissues? 
Could ER stress-induced leptin resis-
tance be mediated independently of 
IKK or through other stress/inflamma-
tory signaling networks such as JNK? A 
recent in vitro study demonstrated that 
ER stress-induced leptin resistance is 
mediated through protein tyrosine phos-
phatase 1B (PTP1B) and can be reversed 
by pretreatment with the chemical chap-
erone PBA (Hosoi et al., 2008). Zhang et  Inc.al. show that another ER chemical chap-
erone, TUDCA, could rescue ER stress 
in the CNS and reduce body weight and 
food intake. Together with the reported 
effects of these chemical chaperones 
in treating insulin resistance, fatty liver 
disease, and type 2 diabetes, Zhang et 
al.’s findings raise the possibility that 
both leptin and insulin resistance in obe-
sity could be simultaneously addressed 
by therapeutic agents that alleviate ER 
stress.
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